Muscle Wasting Disorders Market Size Forecasted To Achieve $29.67 Billion By 2029 With Steady Growth

The Muscle Wasting Disorders Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Muscle Wasting Disorders Market Size and Projected Growth Rate?
The market for muscle wasting disorders has seen rapid expansion in recent years. The market size which was $15.06 billion in 2024 is projected to reach $17.54 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 16.5%. This substantial growth can be linked to an increase in the aging population, a rise in chronic illness incidents, advancements in research and development, heightened consciousness about early detection, and new therapeutic methodologies.

The market size for muscle wasting disorders is predicted to experience a significant expansion in the forthcoming years, aiming to reach $29.67 billion by 2029 with a compound annual growth rate (CAGR) of 14.1%. This anticipated growth during the forecast period is largely due to factors such as regulatory backing, initiatives advocating for patients, advancements in healthcare infrastructure, globalized clinical trials, and the use of personalized medicine approaches. The trend predictions for the forecast period consist of the increased use of telemedicine, technological progress in diagnostics, innovation in products, cooperative ventures and partnerships, advancements in therapeutic methods, research into molecular mechanisms, and innovation in biopharmaceuticals.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13706

What Are the Major Segments in the Muscle Wasting Disorders Market?
The muscle wasting disorders market covered in this report is segmented -

1) By Treatment Type: Medications, Physical Therapy, Nutritional Therapy, Surgery, Gene Therapy, Other Treatment Types
2) By Disorder Type: Muscular Dystrophy, Amyotrophic Lateral Sclerosis (ALS), Other Disorder Types
3) By End-User: Hospitals, Rehab Centers, Specialty Clinics, Other End-Users

Subsegments:
1) By Medications: Anabolic Steroids, Hormonal Treatments, Anti-Inflammatory Drugs, Immunomodulatory Agents
2) By Physical Therapy: Resistance Training, Stretching Exercises, Aerobic Conditioning, Rehabilitation Programs
3) By Nutritional Therapy: Protein s, Nutritional Counseling, Modifications, Micronutrient s
4) By Surgery: Surgical Interventions For Muscle Repair, Orthopedic Surgeries, Procedures For Underlying Conditions
5) By Gene Therapy: Gene Replacement Therapy, CRISPR-Based Approaches, RNA Interference Techniques
6) By Other Treatment Types: Complementary Therapies, Psychological Support, Assistive Devices

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13706&type=smp

What Are The Driving Muscle Wasting Disorders Market Evolution?
The increase in sedentary behavior is anticipated to propel the expansion of the muscle wasting disorders market. A sedentary lifestyle, characterized by an individual's lack of physical activity and minimal engagement in exercise, can have detrimental effects on muscle function. This can result in decreased muscle strength and endurance, leading to muscle wasting disorders and making it challenging for people to maintain muscle mass and function. For example, in 2022, the World Health Organization, an intergovernmental organization based in Switzerland, reported that over 80% of adolescents and 27% of adults were not meeting the advised levels of physical activity. Hence, this escalating adherence to a stationary lifestyle is fueling the growth of the muscle wasting disorders market.

Which Firms Dominate The Muscle Wasting Disorders Market Segments?
Major companies operating in the muscle wasting disorders market report are Pfizer Inc., F. Hoffmann-La Roche Ltd., Roche Holding AG, Novartis AG, Sanofi, GlaxoSmithKline (GSK), Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals, Acceleron Pharma Inc., Biogen Inc., Santhera Pharmaceuticals Holding AG, Mitsubishi Tanabe Pharma, Nippon Shinyaku Co. Ltd. (NS Pharma, Inc.), Sarepta Therapeutics Inc., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Axogen, Inc., FibroGen Inc., Cytokinetics Incorporated, Italfarmaco S.p.A., Scholar Rock, Bellerophon Therapeutics, Akashi Therapeutics, aTyr Pharma, Metabolic Solutions Development Company, Synaptogenix, MyoKardia, Inc., MyoTherix Inc.

What Trends Are Expected to Dominate the Muscle Wasting Disorders Market in the Next 5 Years?
Prominent businesses in the muscle wasting disorders market are pioneering innovative offerings, such as unique gene therapy, to successfully cater to patients suffering from muscle wasting disorders. This novel gene therapy is a progressive medical technology that intends to generate a therapeutic benefit by influencing gene expression or modifying the biological characteristics of living cells. For example, Sarepta Therapeutics, an American biotechnology corporation, in June 2023 made a breakthrough with the launch of Elevidys, the first gene therapy approved by the U.S. Food and Drug Administration (FDA) for treating Duchenne muscular dystrophy (DMD) in paediatric patients aged between 4 and 5 years. Elevidys is a recombinant gene therapy designed to transport into the body a gene which results in a truncated protein encompassing specific domains of the dystrophin protein of normal muscle cells. This product is given as a single intravenous infusion.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/muscle-wasting-disorders-global-market-report

Which Is The Largest Region In The Muscle Wasting Disorders Market?
North America was the largest region in the muscle wasting disorder market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the muscle wasting disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Muscle Wasting Disorders Market?
2. What is the CAGR expected in the Muscle Wasting Disorders Market?
3. What Are the Key Innovations Transforming the Muscle Wasting Disorders Industry?
4. Which Region Is Leading the Muscle Wasting Disorders Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.